Novel methods for delivery of cell-based therapies

Area of Science:

• Biotechnology and Regenerative Medicine
• Pulmonary Medicine
• Neonatal Research

Background:

• Pulmonary hypoplasia (PH) causes significant neonatal mortality, highlighting the need for innovative treatments.
• Engineered tissue substitutes offer a promising avenue for restoring lung function.
• Fetal pulmonary cells (FPC) have been isolated and used to create 3-D lung constructs in vitro.

Purpose of the Study:

• To establish a reliable and reproducible method for delivering FPC into a live animal model of PH.
• To evaluate different delivery routes for FPC to the lungs.

Main Methods:

• Three delivery methods were tested: intraoral, intratracheal, and intrapulmonary injection.
• Fluorescently labeled microspheres and FPC were used to assess delivery and distribution.
• Histological examination, fluorescent microscopy, and immunostaining were employed for outcome analysis.

Main Results:

• Intratracheal injection demonstrated reproducible and diffuse delivery of both microspheres and FPC to the distal alveoli.
• Intraoral delivery was less reliable than direct intratracheal injection.
• Labeled FPC exhibited transepithelial migration, and intrapulmonary injection resulted in localized cell accumulation.

Conclusions:

• Intratracheal injection is the most reliable method for achieving diffuse FPC delivery throughout the lung.
• This study represents a critical step towards site-specific, cell-based therapeutic strategies for PH and related pulmonary conditions.